Abstract
Results Seventy five children out of 715 children followed for JIA presented CU, 69 medical records were analysed. No CU was detected in systemic, RF positive and psoriatic JIA. Sixty CU were observed in 352 oligarticular JIA subtype, 7 in 122 polyarticular and 2 in ERA JIA subtype. 70% of CU were bilateral. Seventy eight percent of CU were diagnosed at systemic examination. CU was anterior in 41 patients and a panuveitis was diagnosed in 18. Complications were observed in 42 patients (61%), and in 29 of them, complications were present at diagnosis. Synechia, hyperpressure and band keratopathy were the most frequent complications. Marked visual loss (< 5/10) was present at first eye examination in 20 children (29%) (50% were bilateral cases). At last examination, visual loss was present in 14 children (20%), and 3 children (4%) were blind. Medical treatment consisted in local steroids, mydriatics, systemic corticosteroids, methotrexate and antiTNF drugs. Twenty-one children underwent surgical treatment. At final examination, only 11 children had presented a favourable outcome. An unfavourable outcome, defined as the need of multiple surgical episodes, was observed in 21 patients. A chronic course with flares is still present in the other 37 patients.
Highlights
Chronic Uveitis (CU) is a severe complication of juvenile idiopathic arthritis (JIA)
We reviewed the clinical course of CU in our JIA patients
Seventy five children out of 715 children followed for JIA presented CU, 69 medical records were analysed
Summary
Chronic Uveitis (CU) is a severe complication of JIA. We reviewed the clinical course of CU in our JIA patients. Ocular threat in juvenile idiopathic arthritis (JIA) I Marvillet*1,2,3, C Terada1, P Quartier1, Bui Quock E1, B Bodaghi1 and Address: 1Pediatric Rheumatology, Hopital Necker Enfants Malades, Paris, France, 2Ophtalmology, Hopital La Pitié, Paris, France and 3Ophtalmology, Hopital Necker Enfants Malades, Paris, France * Corresponding author from 15th Paediatric Rheumatology European Society (PreS) Congress London, UK. Published: 15 September 2008 Pediatric Rheumatology 2008, 6(Suppl 1):P83 doi:10.1186/1546-0096-6-S1-P83
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.